Home Alzheimer’s Disease Optimizing Treatment for Patients with Metastatic Pancreatic Cancer, DNA Repair Defects

Optimizing Treatment for Patients with Metastatic Pancreatic Cancer, DNA Repair Defects

A study published in Clinical Cancer Research found that patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had superior clinical outcomes after platinum-based chemotherapy, as compared to patients without these mutations.1

Moreover, biallelic mutation of homologous recombination (HR) genes showed the best association with this genomic characteristic, independent of germline versus somatic origin. Given these findings, researchers indicated that determining the homologous recombination deficiency (HRD) status is ideally needed at the time of diagnosis to optimize survival and refine treatment selection for this patient population.

“Our data support the use of platinum-based chemotherapy as first-line treatment for patients with defects in various HR genes,” senior author Eileen O’Reilly, MD, medical oncologist at Memorial Sloan…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Cause of Alzheimer’s disease traced to mutation in common enzyme

submitted by /u/scotsman81 Continue Reading to the Source

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Recent Comments